Vascular calcification is heterogeneous and triggered by multiple mechanisms. It has been implicated in the development of heart failure with preserved ejection fraction (HFpEF) and cognitive function impairment. Understanding the pathophysiology of vascular calcification may help us improve the management of HFpEF, atherosclerosis, accelerated arterial stiffness, hypertension, and cognitive dysfunction. Currently, there are no effective strategies for treating accelerated arterial stiffness. This may indicate that once arterial stiffness or vascular calcification has developed, it may be less likely to stop the ongoing pathophysiology. Therefore, earlier intervention targeting the probable pathways of vascular calcification may benefit the patients with vascular calcification and related pathological conditions. In this review, we briefly discuss the proposed pathophysiological roles of vascular calcification in the development of heart failure and cognitive decline, the animal models used to study the link between vascular calcification and cardiovascular diseases, and the possible corresponding management strategies.

Keywords:
Vascular calcification, Arterial stiffness, Hypertension, Cardiovascular disease
1.
McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators: Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753-1760.
2.
Radford NB, DeFina LF, Barlow CE, Lakoski SG, Leonard D, Paixao AR, Khera A, Levine BD: Progression of CAC score and risk of incident CVD. JACC Cardiovasc Imaging 2016;9:1420-1429.
3.
Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR: Porcelain aorta: a comprehensive review. Circulation 2015;131:827-836.
4.
Shaw LJ, Giambrone AE, Blaha MJ, Knapper JT, Berman DS, Bellam N, Quyyumi A, Budoff MJ, Callister TQ, Min JK: Long-term prognosis after coronary artery calcification testing in asymptomatic patients: a cohort study. Ann Intern Med 2015;163:14-21.
5.
Tolle M, Reshetnik A, Schuchardt M, Hohne M, van der Giet M: Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy. Eur J Clin Invest 2015;45:976-985.
6.
Belz GG: Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther 1995;9:73-83.
7.
Mitchell GF: Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension 2004;43:151-153.
8.
Mackey RH, Venkitachalam L, Sutton-Tyrrell K: Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol 2007;44:234-244.
9.
Toussaint ND, Kerr PG: Vascular calcification and arterial stiffness in chronic kidney disease: implications and management. Nephrology (Carlton) 2007;12:500-509.
10.
Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 2002;62:1402-1407.
11.
Bastos Goncalves F, Voute MT, Hoeks SE, Chonchol MB, Boersma EE, Stolker RJ, Verhagen HJ: Calcification of the abdominal aorta as an independent predictor of cardiovascular events: a meta-analysis. Heart 2012;98:988-994.
12.
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259.
13.
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-1955.
14.
Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC: Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-1637.
15.
Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A: Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-2467.
16.
Udelson JE: Heart failure with preserved ejection fraction. Circulation 2011;124:e540-e543.
17.
Paneni F, Diaz Canestro C, Libby P, Luscher TF, Camici GG: The aging cardiovascular system: understanding it at the cellular and clinical levels. J Am Coll Cardiol 2017;69:1952-1967.
18.
Cheng HM, Yu WC, Sung SH, Wang KL, Chuang SY, Chen CH: Usefulness of systolic time intervals in the identification of abnormal ventriculo-arterial coupling in stable heart failure patients. Eur J Heart Fail 2008;10:1192-1200.
19.
Sunagawa K, Maughan WL, Sagawa K: Stroke volume effect of changing arterial input impedance over selected frequency ranges. Am J Physiol 1985;248:H477-H484.
20.
Burkhoff D, Sagawa K: Ventricular efficiency predicted by an analytical model. Am J Physiol 1986;250:R1021-R1027.
21.
Sunagawa K, Maughan WL, Sagawa K: Optimal arterial resistance for the maximal stroke work studied in isolated canine ventricle. Circ Res 1985;56:586-595.
22.
Asanoi H, Sasayama S, Kameyama T: Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 1989;65:483-493.
23.
Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004;350:1953-1959.
24.
Chantler PD, Lakatta EG: Arterial-ventricular coupling with aging and disease. Front Physiol 2012;3:90.
25.
Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97.
26.
Markus HS: Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry 2004;75:353-361.
27.
Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ: Arterial stiffness, pressure and flow pulsatility and brain structure and function: The Age, Gene/Environment Susceptibility - Reykjavik Study. Brain 2011;134:3398-3407.
28.
Zeki Al Hazzouri A, Newman AB, Simonsick E, Sink KM, Sutton Tyrrell K, Watson N, Satterfield S, Harris T, Yaffe K: Pulse wave velocity and cognitive decline in elders: the health, aging, and body composition study. Stroke 2013;44:388-393.
29.
Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss-Lejeune MM, Hofman PA, Lodder J, de Leeuw PW: Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension 2008;52:1120-1126.
30.
Hughes TM, Kuller LH, Barinas-Mitchell EJ, Mackey RH, McDade EM, Klunk WE, Aizenstein HJ, Cohen AD, Snitz BE, Mathis CA, Dekosky ST, Lopez OL: Pulse wave velocity is associated with beta-amyloid deposition in the brains of very elderly adults. Neurology 2013;81:1711-1718.
31.
Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC: Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 2007;9:440-449.
32.
Jefferson AL, Beiser AS, Himali JJ, Seshadri S, O'Donnell CJ, Manning WJ, Wolf PA, Au R, Benjamin EJ: Low cardiac index is associated with incident dementia and Alzheimer disease: The Framingham Heart Study. Circulation 2015;131:1333-1339.
33.
Jefferson AL, Himali JJ, Beiser AS, Au R, Massaro JM, Seshadri S, Gona P, Salton CJ, DeCarli C, O'Donnell CJ, Benjamin EJ, Wolf PA, Manning WJ: Cardiac index is associated with brain aging: The Framingham Heart Study. Circulation 2010;122:690-697.
34.
Alosco ML, Brickman AM, Spitznagel MB, van Dulmen M, Raz N, Cohen R, Sweet LH, Colbert LH, Josephson R, Hughes J, Rosneck J, Gunstad J: The independent association of hypertension with cognitive function among older adults with heart failure. J Neurol Sci 2012;323:216-220.
35.
Komori T, Eguchi K, Saito T, Nishimura Y, Hoshide S, Kario K: Riser blood pressure pattern is associated with mild cognitive impairment in heart failure patients. Am J Hypertens 2016;29:194-201.
36.
Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB: Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol 2003;14:2466-2474.
37.
Buzello M, Tornig J, Faulhaber J, Ehmke H, Ritz E, Amann K: The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003;14:311-316.
38.
Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA: Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 2010;25:2679-2685.
39.
Price PA, Faus SA, Williamson MK: Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000;20:317-327.
40.
Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke SK, Fukushima N: Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 2003;64:441-450.
41.
Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, Moe OW, Giachelli CM: Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int 2012;82:1261-1270.
42.
Torres PA, De Broe M: Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. Kidney Int 2012;82:19-25.
43.
Carney EF: Chronic kidney disease: no significant effect of cinacalcet on cardiovascular outcomes in patients undergoing dialysis - EVOLVE results. Nat rev Nephrol 2013;9:4.
44.
Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O'Neill WC: Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 2009;75:617-625.
45.
Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis 2010;56:57-68.
46.
Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, Kostenuik PJ, Erben RG, Hofbauer LC: Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol 2009;175:473-478.
47.
Cho HJ, Cho HJ, Lee HJ, Song MK, Seo JY, Bae YH, Kim JY, Lee HY, Lee W, Koo BK, Oh BH, Park YB, Kim HS: Vascular calcifying progenitor cells possess bidirectional differentiation potentials. PLoS Biol 2013;11:e1001534.
48.
Iijima K, Ito Y, Son BK, Akishita M, Ouchi Y: Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification. J Atheroscler Thromb 2014;21:917-929.
49.
Chen NX, O'Neill KD, Chen X, Kiattisunthorn K, Gattone VH, Moe SM: Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol 2011;34:211-219.
50.
Cao X, Li H, Tao H, Wu N, Yu L, Zhang D, Lu X, Zhu J, Lu Z, Zhu Q: Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology 2013;154:3680-3689.
51.
Brodeur MR, Bouvet C, Bouchard S, Moreau S, Leblond J, Deblois D, Moreau P: Reduction of advanced-glycation end products levels and inhibition of rage signaling decreases rat vascular calcification induced by diabetes. PLoS One 2014;9:e85922.
52.
Lei Y, Grover A, Sinha A, Vyavahare N: Efficacy of reversal of aortic calcification by chelating agents. Calcif Tissue Int 2013;93:426-435.
53.
Shimomura A, Matsui I, Hamano T, Ishimoto T, Katou Y, Takehana K, Inoue K, Kusunoki Y, Mori D, Nakano C, Obi Y, Fujii N, Takabatake Y, Nakano T, Tsubakihara Y, Isaka Y, Rakugi H: Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol 2014;25:1954-1965.
54.
Peralta-Ramirez A, Montes de Oca A, Raya AI, Pineda C, Lopez I, Guerrero F, Diez E, Munoz-Castaneda JR, Martinez J, Almaden Y, Rodriguez M, Aguilera-Tejero E: Vitamin e protection of obesity-enhanced vascular calcification in uremic rats. Am J Physiol Renal Physiol 2014;306:F422-F429.
55.
Tadic M, Cuspidi C, Hering D: Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden. BMC Cardiovasc Disord 2016;16:208.
56.
Levi Marpillat N, Macquin-Mavier I, Tropeano AI, Bachoud-Levi AC, Maison P: Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens 2013;31:1073-1082.
57.
Vo TM, Disthabanchong S: Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease? World J Cardiol 2014;6:216-226.
58.
Speer MY, Giachelli CM: Regulation of cardiovascular calcification. Cardiovasc Pathol 2004;13:63-70.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.